共 4 条
Inhibition of hypusination of eukaryotic initiation factor 5a (eIF5A) as a novel a synergistic treatment strategy in imatinib-treated BCR-ABL positive leukemias identified by a global proteomics approach
被引:1
|作者:
Balabanov, S
Ziegler, P
Hartmann, U
Kammer, W
Copland, M
Priemer, M
Wilhelm, T
Bokemeyer, C
Kanz, L
Holyoake, T
Nordheim, A
Bruemmendorf, T
机构:
[1] Univ Hamburg, Hosp Eppendorf, Dept Hematol Oncol & BMT, D-20246 Hamburg, Germany
[2] Univ Tuebingen, Med Ctr, Dept Hematol Oncol & Immunol, Tubingen, Germany
[3] Univ Tuebingen, Ctr Bioinformat, ZBiT Proteom, Tubingen, Germany
[4] Univ Glasgow, Sect Expt Hematol, Canc Div, Glasgow, Lanark, Scotland
[5] Univ Tuebingen, Inst Cell & Mol Biol, Tubingen, Germany
[6] Univ Tuebingen, Proteome Ctr, Tubingen, Germany
来源:
关键词:
D O I:
10.1182/blood.V106.11.1997.1997
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
1997
引用
收藏
页码:565A / 566A
页数:2
相关论文